Table 2. List of registered clinical trials involving Selinexor in various malignancies (44).
| # | NCT number | Conditions |
|---|---|---|
| 1 | NCT03193437 | Thymoma |
| 2 | NCT03095612 | NSCLC |
| 3 | NCT03147885 | Lymphoma (various types) |
| 4 | NCT02606461 | Liposarcoma |
| 5 | NCT02249091 | AML |
| 6 | NCT01986348 | Glioblastoma, glioma |
| 7 | NCT02402764 | Breast cancer |
| 8 | NCT02227251 | DLBCL |
| 9 | NCT02250885 | Neuroendocrine carcinoma |
| 10 | NCT02025985 | Ovarian, endometrial, cervical, breast cancer |
| 11 | NCT02530476 | Leukemia |
| 12 | NCT02403310 | Leukemia |
| 13 | NCT02471911 | DLBCL |
| 14 | NCT02336815 | MM |
| 15 | NCT02389543 | MM |
| 16 | NCT02323880 | Childhood CNS/solid neoplasm, lymphoma |
| 17 | NCT03466827 | Thymoma |
| 18 | NCT02078349 | Solid tumors |
| 19 | NCT02485535 | AML, MDS |
| 20 | NCT02283359 | Esophageal, gastric cancer |
| 21 | NCT02215161 | Prostate cancer |
| 22 | NCT02831686 | MM |
| 23 | NCT02573363 | AML |
| 24 | NCT02199665 | MM |
| 25 | NCT02314247 | T-cell lymphoma |
| 26 | NCT02835222 | AML |
| 27 | NCT02138786 | Richter’s transformation |
| 28 | NCT02228525 | MDS |
| 29 | NCT02120222 | Melanoma |
| 30 | NCT02091245 | Leukemia |
| 31 | NCT02741388 | B-cell lymphoma |
| 32 | NCT02212561 | AML, ALL, MDS, MPAL |
| 33 | NCT03042819 | Soft tissue sarcoma |
| 34 | NCT02213133 | Squamous cell carcinoma |
| 35 | NCT02780609 | MM |
| 36 | NCT02431351 | MDS |
| 37 | NCT02384850 | Colorectal neoplasm |
| 38 | NCT02186834 | MM |
| 39 | NCT02299518 | AML |
| 40 | NCT01607905 | Solid tumor |
| 41 | NCT02351505 | SCLC |
| 42 | NCT02343042 | MM |
| 43 | NCT02628704 | MM |
| 44 | NCT03555422 | Endometrial cancer |
| 45 | NCT02146833 | Prostate cancer |
| 46 | NCT03212937 | T-cell lymphoma |
| 47 | NCT02536495 | Squamous cell lung carcinoma |
| 48 | NCT02269293 | Ovarian, endometrial cancer |
| 49 | NCT02137356 | Rectal neoplasms |
| 50 | NCT02093403 | AML |
| 51 | NCT02303392 | Leukemia, lymphoma |
| 52 | NCT01607892 | Hematological malignancies |
| 53 | NCT03071276 | AML |
| 54 | NCT02178436 | Pancreatic cancer |
| 55 | NCT03110562 | MM |
| 56 | NCT02088541 | AML |
| 57 | NCT02416908 | AML |
| 58 | NCT02069730 | Salivary gland cancer |
| 59 | NCT01896505 | Sarcoma |
| 60 | NCT02419495 | Advanced cancers |
NSCLC, non-small cell lung cancer; AML, acute myeloid leukemia; DLBCL, diffuse large B-cell lymphoma; MM, multiple myeloma; CNS, central nervous system; MDS, myelodysplastic syndrome; ALL, acute lymphoblastic leukemia; MPAL, mixed phenotype acute leukemia; SCLC, small cell lung cancer.